Ming Changsheng, Zeng Fanjun, Sha Bo, Chen Zhonghua, Chen Zhishui, Lin Zhengbin, Zhang Weijie, Liu Bin, Jiang Jipin, Wei Lai, Chen Shi
Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Hua Zhong University of Science and Technology, Wuhan 430030, China.
Zhonghua Yi Xue Za Zhi. 2002 Nov 25;82(22):1514-7.
To evaluate simultaneous kidney-pancreatic transplantation (SKPT) with bladder drainage and enteric drainage for its efficacy and safety.
SKPT was performed in 10 patients from Jan. 2000 to Feb. 2002. All patients had long-standing insulin-dependent diabetes mellitus and subsequent renal failure. Bladder drainage (BD) of exocrine secretion was used in the first 2 cases and enteric drainage (ED) in last 8 patients. In BD, a two-layer hand sewn duodenocystostomy was performed. In ED, a two-layered side-to-side anastomosis was fashioned between the donor duodenal segment and the recipient jejunum. No Roux-en-Y limb was used. Quadruple immunosuppressive therapy with antithymocyte globulin, tacrolimus, mycophenolate mofetil and steroids was standard treatment in all patients. The patients were treated with quadruple therapy, which included antilymphocyte globulin (ALG) or anti-CD25 monoclonal antibody (Zenapax) induction therapy, prednisone, Cyclosporine A/tacrolimus, and mycophenolat-mofetil (MMF).
SPK was successfully applied to all cases without complication referable to the technique. All patients have achieved excellent renal function and euglycemia, and no further insulin treatment was needed between 1 and 5 days posttransplant. One patient with ED died due to sepsis and upper gastrointestinal hemorrhage 5 weeks after operation. The death occurred with functioning grafts. Until now no rejection episode and thrombosis were observed and all the grafts from nine patients are functioning well. The first 2 patients with BD underwent slight metabolic complications and microscopic hematuria with entire follow-up time. Two episodes of reflux graft pancreatitis followed by macroscopic hematuria occurred in one patient with BD.
Compared with SPK with BD, ED without Roux-en-Y anastomosis might be a more physiological and prior procedure for type I diabetes mellitus with uremia.
评估膀胱引流和肠道引流的同期肾胰联合移植(SKPT)的疗效和安全性。
2000年1月至2002年2月期间,对10例患者实施了SKPT。所有患者均患有长期胰岛素依赖型糖尿病并继发肾衰竭。前2例采用外分泌液膀胱引流(BD),后8例采用肠道引流(ED)。在BD组,进行了两层手工缝合的十二指肠囊肿造口术。在ED组,在供体十二指肠段与受体空肠之间进行了两层侧侧吻合。未使用Roux-en-Y肠袢。所有患者均采用抗胸腺细胞球蛋白、他克莫司、霉酚酸酯和类固醇的四联免疫抑制疗法作为标准治疗。患者接受四联疗法治疗,包括抗淋巴细胞球蛋白(ALG)或抗CD25单克隆抗体(舒莱)诱导治疗、泼尼松、环孢素A/他克莫司和霉酚酸酯(MMF)。
SPK成功应用于所有病例,未出现与技术相关的并发症。所有患者均实现了良好的肾功能和血糖正常,移植后1至5天内无需进一步胰岛素治疗。1例ED患者术后5周因败血症和上消化道出血死亡。死亡发生时移植物功能良好。截至目前,未观察到排斥反应和血栓形成,9例患者的所有移植物功能良好。前2例BD患者在整个随访期间出现了轻微的代谢并发症和镜下血尿。1例BD患者发生了2次反流性移植胰腺炎,随后出现肉眼血尿。
与BD的SPK相比,不进行Roux-en-Y吻合的ED可能是I型糖尿病合并尿毒症更符合生理且优先选择的术式。